Neurological conditions top cardiovascular disease as chunk of global disease burden, report finds
By
Kristen Fischer
Mar 15, 2024
Neurological conditions affected about 43% of all people on the globe in 2021 — beating out cardiovascular diseases as the top contributor to global disease burden, according to a new report.
Report: ADHD diagnostic, treatment resources lacking for people over 50
By
Kristen Fischer
Sep 20, 2023
Doctors need more guidance on helping people who are over 50 and have attention deficit hyperactivity disorder (ADHD) as most of the attention is on young adults and children, according to a new report....
COVID linked to high rates of lasting dementia, psychosis, large study finds
By
Alicia Lasek
Aug 19, 2022
The risk of neurological symptoms related to COVID-19 remains high for at least two years after infection, while psychiatric symptoms fade within about two months, a large new study has found.
COVID-19 patients face higher risk of neurodegenerative disorders: study
By
Alicia Lasek (f3)
Jul 01, 2022
People who test positive for COVID-19 are at an increased risk of Alzheimer’s disease, Parkinson’s disease and ischemic stroke, a large new study finds.
Ethical guidance issued for palliative care in neurologic disease
By
Alicia Lasek
Mar 09, 2022
The updated recommendations cover issues encountered by physicians who care for people living with life-altering illnesses such as stroke, Parkinson’s disease and amyotrophic lateral sclerosis.
Levodopa is ‘best first treatment’ for early Parkinson’s, new guideline states
By
Alicia Lasek
Nov 17, 2021
When compared to alternative options, levodopa provides a superior risk-benefit profile when used to alleviate motor symptoms, and patients are less likely to stop treatment, according to the American...
New dashboard to track ‘Long COVID’ cases for healthcare planning
By
Alicia Lasek
Aug 25, 2021
The dashboard will track state and county level statistics and trends. The goal is to provide data to healthcare decision makers as they prepare to care for patients with lingering symptoms, says the American...
Clinical briefs for Thursday, July 15
By
Alicia Lasek
Jul 15, 2021
FDA adds provider warning to J&J vaccine regarding rare neurological disorder … Biogen’s dementia drug Aduhelm could cost Medicaid up to $2.2 billion a year … Biden to nominate West Virginia’s...
Brain implants continue to reduce Parkinson’s motor symptoms 15 years later
By
Alicia Lasek
Jun 11, 2021
The amount of time study participants experienced dyskinesia was reduced by 75%, and use of levodopa was reduced by 51% — long after deep brain stimulation devices were implanted.
Pre-existing neurological conditions forecast COVID survivors’ need for ongoing care
By
Alicia Lasek
May 12, 2021
In one group of hospitalized COVID patients, 82% had self-reported or clinically diagnosed neurological symptoms. “Even if the pandemic is completely eradicated, we are still talking about millions of...